| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.8 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.8 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.9 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.9 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.9 |